N.O.max ER

product on market Tablet or Pill XYMOGEN 🟢 Safety: 100/100
Brand: XYMOGEN
🟢 100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • Limited research evidence available for ingredients
B Label Compliance Grade

Product Label

Label for N.O.max ER
📄 Open Full PDF View on NIH DSLD →
📸

Have a supplement label? Find it here.

Upload a photo of any supplement label to search our database of 92,312 products.

Label Data

3 Tablet(s) Serving Size
60 Servings
Other Combinations Product Type
0% Evidence Coverage

Supplement Facts — Evidence Check

1.98 Gram(s)
📊 Market median: 500.0mg (143 products)
This product: 1.98mg
ActiNOS
150 mg

Other Ingredients

Hydroxypropyl Methylcellulose Stearic Acid Hydroxypropyl Cellulose Silica Hydroxypropyl Methylcellulose Medium Chain Triglyceride Magnesium Stearate

Label Claims — Verification

❓ Nutrient
❓ All Other
❓ Structure/Function
All Other (100% of products) Structure/Function (91% of products) Nutrient (35% of products)

Target Groups

Adult (18 - 50 Years) Gluten Free

Product Information

📋 Directions for Use

Directions: Take three tablets twice per day: 3 tablets 30 minutes before breakfast and 3 tablets again 30 minutes before lunch with 8 ounces of water.

⚠️ Warnings & Precautions

Cautions: Consult your healthcare professional prior to use, especially if you have or suspect you have a medical condition, including diabetes or cold sores; if you take prescription drugs or are allergic to any ingredient; or if you are pregnant or lactating.

Keep out of reach of children. This product is not intended for use by individuals under 18 years of age.

Do not use if tamper seal is damaged.

Storage: Keep closed in a cool, dry place out of reach of children.

Contains: Milk

Cautions: Consult your healthcare professional prior to use, especially if you have or suspect you have a medical condition, including diabetes or cold sores; if you take prescription drugs or are allergic to any ingredient; or if you are pregnant or lactating.

🧪 Formulation Notes

N.O. max ER represents an extended-release nitric oxide precursor. Scientists now refer to nitric oxide (NO) as the "foundation" of cardiovascular health. This tiny molecule is a vasodilator responsible for controlling blood flow to the entire body, which may help support healthy blood flow pressure and promote the health of the endothelium-the inside of blood vessels. With age comes diminished NO levels; that's why since 1998, when three scientists won the Nobel Prize for their discovery of NO, researchers have been working to harness its heart-healthy activity. Today, with the application of XYMOGEN's extended-release technology, that activity has been realized with N.O. max ER.

Formulated to Exclude: Wheat, gluten, yeast, soy, fish, shellfish, peanuts, tree nuts, egg, sesame, ingredients derived from genetically modified organisms (GMOs), artificial colors, artificial sweeteners, and artificial preservatives.

Extended-Release Arginine Alpha-Ketoglutarate Clinically-Tested Ingredient

Additional Information

Storage: Keep closed in a cool, dry place out of reach of children.

ePV (ePedigree Verification) Third-Party Verified GMP Compliant

Scan to Learn More! This package is completely recyclable

Product Details

UPC / SKU 8 71149 00164 3
DSLD Entry Date 2023-12-14
Product Type Other Combinations
Form Tablet or Pill
Brand XYMOGEN
DSLD ID 303764
Data Updated 2026-04-11

Research Evidence

45 Research Sources
52 Avg Quality Score
12 Rct
11 Systematic Review
11 Meta Analysis
11 Clinical Trial
A Nitric oxide donors (nitrates), L-arginine, or nitric oxide synthase inhibitors for acute stroke
Meta Analysis The Cochrane database of systematic reviews 2017
PubMed DOI Cochrane
A Arginine supplementation for prevention of necrotising enterocolitis in preterm infants
Meta Analysis The Cochrane database of systematic reviews 2017
PubMed DOI Cochrane
B Nutritional interventions for treating foot ulcers in people with diabetes
Meta Analysis The Cochrane database of systematic reviews 2020
PubMed DOI
B Nitric oxide donors (nitrates), L-arginine, or nitric oxide synthase inhibitors for acute stroke
Systematic Review The Cochrane database of systematic reviews 2002
PubMed Cochrane
B Arginine supplementation for prevention of necrotising enterocolitis in preterm infants
Systematic Review The Cochrane database of systematic reviews 2007
PubMed Cochrane
B The Effect of Amino Acids on Wound Healing: A Systematic Review and Meta-Analysis on Arginine and Glutamine
Meta Analysis Nutrients 2021
PubMed DOI
B Nitric oxide donors (nitrates), L-arginine, or nitric oxide synthase inhibitors for acute ischaemic stroke
Systematic Review The Cochrane database of systematic reviews 2000
PubMed Cochrane
B Dietary Supplements for Erectile Dysfunction: Analysis of Marketed Products, Systematic Review, Meta-Analysis and Rational Use
Meta Analysis Nutrients 2023
PubMed DOI
B Arginine supplementation for prevention of necrotising enterocolitis in preterm infants
Systematic Review The Cochrane database of systematic reviews 2004
PubMed Cochrane
B An Analysis of Popular Online Erectile Dysfunction Supplements
Systematic Review The journal of sexual medicine 2019
PubMed DOI
View all evidence for L Arginine →

Compare Similar Products

Bio-Tone
Bio-Tone NeoLife Sport 100
Total Arginine
Total Arginine Nutri-West 100
L-Arginine 500 mg Indiana Botanic Gardens 100
Nitrulline
Nitrulline BodyTech Elite 100
L-Arginine 1000 mg TN Trusted Nutrients 100
View all L Arginine products →
L Arginine research & evidence Best L Arginine rankings All L Arginine products More from XYMOGEN View on NIH DSLD →